David Trower, Anonymisation and pseudonymisation in large data sets for medical research

Anonymisation & pseudonymisation in large data sets for medical research Law and Ethics in e-Social Science Workshop, 24 June 2009

David Trower Chief Privacy Officer EMEA & Chair of Global Privacy Council IMS Health

Who are IMS? ,[object Object],[object Object],[object Object],[object Object]

Why is privacy so important to IMS? ,[object Object],[object Object],[object Object],[object Object],[object Object]

Our privacy gold standard ,[object Object],[object Object],[object Object],[object Object]

Legal and regulatory considerations ,[object Object],[object Object],[object Object],[object Object],[object Object]

Data protection law requirements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

The alternative is to anonymise ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Is pseudonymised data ‘personal’? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Secondary use of patient data at IMS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Purposes ,[object Object],[object Object],[object Object],[object Object],[object Object]

Types of survey ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

IMS anonymisation standard on full medical record ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Is physician linked prescription data personal? ,[object Object],[object Object],[object Object],[object Object],[object Object]

Is physician linked prescription data personal? Article 29 Working Party, committee of all EU DP commissioners, produced guidance on definition of personal data in 2007. Example 1: Professional habits and practices Drug prescription information (e.g. drug identification number, drug name, drug strength, manufacturer, selling price, new or refill, reasons for use, reasons for no substitution order, prescriber's first and last name, phone number, etc.), whether in the form of an individual prescription or in the form of patterns discerned from a number of prescriptions, can be considered as personal data about the physician who prescribes this drug, even if the patient is anonymous. Thus, providing information about prescriptions written by identified or identifiable doctors to producers of prescription drugs constitutes a communication of personal data to third party recipients in the meaning of the Directive.

IMS EMEA response ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

David Trower, Anonymisation and pseudonymisation in large data sets for medical research

Recommandé

Recommandé

Contenu connexe

Similaire à David Trower, Anonymisation and pseudonymisation in large data sets for medical research

Similaire à David Trower, Anonymisation and pseudonymisation in large data sets for medical research (20)

Dernier

Dernier (20)

David Trower, Anonymisation and pseudonymisation in large data sets for medical research